Fukui S, Numata Y, Kurosaka A, Kitagawa H, Nakada H, Funakoshi I, Kawasaki T, Takahashi Y, Hayashi K, Yamashina I
Department of Biological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University.
Jpn J Cancer Res. 1988 Oct;79(10):1119-29. doi: 10.1111/j.1349-7006.1988.tb01535.x.
Through the use of a technique for raising monoclonal antibodies, coupled with a solid-phase radioimmunoassay utilizing immobilized glycopeptides prepared from the surface membranes of the colorectal cancer cells (LS 180) used for the immunization, carbohydrate-directed monoclonal antibodies were obtained. One of the monoclonal antibodies, MLS 102, reacted immunohistochemically intensely with the colorectal cancer cell surface and the mucinous glycoproteins secreted by the cancer cells, but only weakly with normal colon tissue. The antigenic determinant recognized by MLS 102 was the carbohydrate moiety of glycoproteins with terminal sialic acid. The antigens defined by other monoclonal antibodies, MLS 103 and 104, were immunohistochemically detected in both normal colonic epithelial and cancer cells. These antibodies seemed to recognize the carbohydrate moieties of both glycoproteins and glycolipids. The method described in this report can be generally applied to raise cell surface carbohydrate-directed antibodies.
通过使用一种产生单克隆抗体的技术,结合利用从用于免疫的结肠癌细胞(LS 180)表面膜制备的固定化糖肽的固相放射免疫测定法,获得了碳水化合物导向的单克隆抗体。其中一种单克隆抗体MLS 102在免疫组织化学上与结肠癌细胞表面和癌细胞分泌的粘液糖蛋白强烈反应,但与正常结肠组织反应较弱。MLS 102识别的抗原决定簇是具有末端唾液酸的糖蛋白的碳水化合物部分。其他单克隆抗体MLS 103和104所定义的抗原在正常结肠上皮细胞和癌细胞中均通过免疫组织化学检测到。这些抗体似乎识别糖蛋白和糖脂的碳水化合物部分。本报告中描述的方法通常可用于产生细胞表面碳水化合物导向的抗体。